
Hualan Biological Engineering Inc. — Investor Relations & Filings
Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于用自有资金进行投资理财的公告 | 2015-03-27 | Chinese | |
| 2014年度业绩快报 | 2015-02-26 | Chinese | |
| 详式权益变动报告书 | 2015-02-16 | Chinese | |
| 简式权益变动报告书 | 2015-02-16 | Chinese | |
| 关于第一大股东注册信息变更的公告 | 2015-02-16 | Chinese | |
| 关于同一实际控制人下股份转让的提示性公告 | 2015-02-16 | Chinese |
Browse filings by year
23 years- 2026 41 filings
- 2025 101 filings
- 2024 50 filings
- 2023 70 filings
- 2022 73 filings
- 2021 57 filings
- 2020 85 filings
- 2019 58 filings
- 2018 74 filings
- 2017 52 filings
- 2016 66 filings
- 2015 82 filings
- 2014 80 filings
- 2013 91 filings
- 2012 59 filings
- 2011 58 filings
- 2010 60 filings
- 2009 73 filings
- 2008 84 filings
- 2007 72 filings
- 2006 57 filings
- 2005 59 filings
- 2004 25 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2015
14 filings
| |||||
| 44305869 | 关于用自有资金进行投资理财的公告 | 2015-03-27 | Chinese | ||
| 44305859 | 2014年度业绩快报 | 2015-02-26 | Chinese | ||
| 44305854 | 详式权益变动报告书 | 2015-02-16 | Chinese | ||
| 44305838 | 简式权益变动报告书 | 2015-02-16 | Chinese | ||
| 44305804 | 关于第一大股东注册信息变更的公告 | 2015-02-16 | Chinese | ||
| 44305799 | 关于同一实际控制人下股份转让的提示性公告 | 2015-02-16 | Chinese | ||
| 44305784 | 关于为参股公司提供担保的进展公告 | 2015-02-13 | Chinese | ||
| 44305770 | 关于控股子公司取得H7N9流感疫苗临床试验批件的公告 | 2015-01-28 | Chinese | ||
| 44305763 | 关于对外提供委托贷款的进展公告 | 2015-01-15 | Chinese | ||
| 44305720 | 关于对外提供委托贷款的公告 | 2015-01-05 | Chinese | ||
| 44305698 | 关于放弃参股公司股权优先受让权的公告 | 2015-01-05 | Chinese | ||
| 44305686 | 第五届董事会第十五次会议决议公告 | 2015-01-05 | Chinese | ||
| 44305670 | 独立董事对公司第五届董事会第十五次会议相关事项的独立意见 | 2015-01-05 | Chinese | ||
| 44305655 | 第五届监事会第十五次会议决议公告 | 2015-01-05 | Chinese | ||
|
2014
1 filing
| |||||
| 44305639 | 关于参股子公司单克隆抗体药物研发进展的公告 | 2014-12-19 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Hualan Biological Engineering Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54073/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54073 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54073 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54073 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54073}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Hualan Biological Engineering Inc. (id: 54073)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.